2024 Update in Hematology and Medical Oncology — On Demand

Overview

The Memorial Sloan Kettering 12th Annual Hematology and Medical Oncology Board Review is a four day course that provides an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures provided by expert faculty will focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, central nervous system oncology, and hematologic oncology. Ample time will be provided at the conclusion of each presentation for an interactive question-and-answer session with the speakers.

Attendees of this course will receive access to an online syllabus, which includes select PDFs of presentations (slides) and video recordings of the lectures.

Target Audience

The target audience for this program is medical oncology professionals, including physicians, nurses, pharmacists, fellows, and residents. This course is designed to enable participants to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology.

This course is set to be an exclusively live virtual experience. Detailed Zoom access and participation instructions will be provided to registrants prior to the start of the program.

Objectives

At the conclusion of this on demand, learners will be able to:

1. Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
2. Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
3. Prepare for ABIM examinations in medical oncology and hematology.